SP2TX
SP2TX delivers faster, cheaper peptide drug development through a novel synthesis platform. Its FLOWSMART system merges solid phase peptide synthesis with AI-guided, resin-based flow chemistry to produce peptides at scale. This B2B platform targets biopharma and biotech research groups. It is designed for integration with common analytical and purification workflows and builds on expertise in resin chemistry, bioinformatics, engineering, and machine learning. As a spinout from Seoul National University's Institute of Molecular Biology and Genetics, SP2TX aims to accelerate peptide drug development.
SP2TX
SP2TX delivers faster, cheaper peptide drug development through a novel synthesis platform. Its FLOWSMART system merges solid phase peptide synthesis with AI-guided, resin-based flow chemistry to produce peptides at scale. This B2B platform targets biopharma and biotech research groups. It is designed for integration with common analytical and purification workflows and builds on expertise in resin chemistry, bioinformatics, engineering, and machine learning. As a spinout from Seoul National University's Institute of Molecular Biology and Genetics, SP2TX aims to accelerate peptide drug development.